Study on the Effectiveness and Safety of Ifinatamab Deruxtecan (I-DXd) for Recurrent or Metastatic Solid Tumors | Clinical Trial

Study on the Effectiveness and Safety of Ifinatamab Deruxtecan (I-DXd) for Recurrent or Metastatic Solid Tumors | Clinical Trial | Right2Hope